摘要
目的研究新发涂阳肺结核病人完成标准短程化疗后的远期疗效。方法采用全程间歇短程化疗方案(2H3R3Z3E3/4H3R3或2H3R3Z3S3/4H3R3)对新发涂阳肺结核病人实施全程督导管理,完成疗程后随访两年判断疗效。结果新发涂阳肺结核病人完成疗程后治愈率为97.7%,随访一年内复发率为3%,二年内复发率为1.68%。结论实施全程督导标准化疗方案对新发涂阳肺结核病人不仅近期疗效满意,同样,取得了满意的远期疗效。
Objective To study of the long-term effects of new smear-positive pulmonary tuberculosis with standard short-course chemotherapy. Methods New smear-positive pulmonary tuberculosis was treated with 2H3R3Z3E3/4H3R3or2H3R3Z3S3/4H3R3 under full-course management follow up examination after 2 years. Results The cure rate of new smear-positive pulmonary tuberculosis was 97.7%at the end of treatment the relapse rate was 2.98% after 1 year 1.68% after 2 year. Conclusions The short-term effects of newly diagnosed smear-positive pulmonary tuberculosis with short-course chemotherapy was satisfactory so does the long-term effects.
出处
《海南医学》
CAS
2005年第5期11-11,10,共2页
Hainan Medical Journal
关键词
结核
肺/预防和控制
疗效
Tuberculosis Pulmonary/prevention and control Chemotherapy
